Skip to main content
Undue Pharmaceutical Influence on Psychiatric Practice
Counseling and School Psychology Faculty Publication Series
  • Lisa Cosgrove, University of Massachusetts Boston
  • Harold J. Bursztajn, Harvard University
Document Type
Publication Date
Within the past few years, increasing concerns have arisen about the ways in which corporate sponsorship of clinical trials and continuing medical education activities may bias the information that is published and disseminated about the benefits and risks of medications. Questions have also been raised about the extent of industry influence on the American Psychiatric Association’s diagnostic and treatment guidelines—namely, its DSM and Clinical Practice Guidelines.

This article appears in the Psychiatric Times, published by UBM Medica LLC:

Community Engaged/Serving
No, this is not community-engaged.
UBM Medica LLC
Citation Information
Cosgrove, Lisa and Harold J. Bursztajn, "Undue Pharmaceutical Influence on Psychiatric Practice" Psychiatric Times (May 18, 2010).